196170.KQ Alteogen Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
08:00
Apr 26
Lee Young-hoon, Director Director, Unknown 815 Money Talk (815머니톡)
Validated platform, bottoming, limited downside.
Alteogen, a large-cap biotech with a validated platform and a significant licensing deal, has limited downside risk at current levels. The stock is bottoming and showing signs of a rebound, making it attractive for a rebound trade as the sector stabilizes.
196170.KQ 1ST
MED
09:21
Apr 20
Bonho 3PRO TV (삼프로TV)
Alteogen patent risk removed.
Alteogen's patent registration for ALT-B4 removes a key risk, driving the stock higher, and it remains a strong biotech pick.
196170.KQ 1ST
HIGH

About 196170.KQ Analyst Coverage

Buzzberg tracks 196170.KQ (Alteogen) across 2 sources. 2 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked.